The Crescendo Difference
We are creating comprehensive models of disease biology through our deep expertise in genetics, gene expression and quantitative protein analysis. We are also establishing long-term, collaborative relationships with physicians by providing comprehensive diagnostic, prognostic, analysis, therapy selection and monitoring capabilities to improve outcomes over the lifetime of each patient.
Crescendo Bioscience concentrates its efforts in rheumatology and is currently focused on rheumatoid arthritis (RA), a debilitating, chronic disease affecting over 1.5 million people in the United States and more than 2 million in Europe. Although there is no known cure for RA, multiple therapies are available, with widely differing levels of effectiveness and significant potential toxicities. Choosing the optimal treatment from among these therapeutic alternatives is a tremendous challenge.
Federal CLIA Certificate
The Centers for Medicare & Medicaid Services (CMS) regulate all laboratory testing performed on humans in the U.S. through the Clinical Laboratory Improvement Amendments (CLIA). The objective of the CLIA program is to ensure quality laboratory testing. www.cms.gov
New York State Clinical Laboratory Permit
The Wadsworth Center at the New York Department of Health through its Clinical Laboratory Evaluation Program (CLEP) issued a laboratory permit to Crescendo Bioscience to provide services to physicians/patients in New York. The excellence of the CLEP program has been acknowledged by CMS through their granting of exempt status from the federal CLIA for laboratories located in and holding NYS clinical laboratory permits.
CMS coverage policy issued by Palmetto GBA for Vectra DA
Palmetto GBA posted a favorable coverage article for Vectra DA on May 10, 2013 under the Medicare Part B program, which also drives coverage policies for the large Medicare Advantage Plans.
CAP Laboratory Accreditation Program
The commission on Laboratory Accreditation of the College of American Pathologists (www.cap.org) examined Crescendo Bioscience’s laboratory records and quality control procedures for the preceding 2 years. In addition, staff qualifications, laboratory equipment, and the facility’s safety program and record, as well as the overall lab management were examined.